type II diabetes mellitus
Replacement of angiotensin-converting enzyme inhibitors by       angiotensin-II-receptor antagonists in hypertensive patients with type II       diabetes mellitus: metabolic and hemodynamic consequences.
Replacement of angiotensin-converting enzyme inhibitors by       angiotensin-II-receptor antagonists in hypertensive  @OBJECT$   @PREDICAT$   @SUBJECT$ : metabolic and hemodynamic consequences.